Chien‐Hsing Lu

机构：National Taichung University of Science and Technology, International Baccalaureate, National Chung Hsing University, Taichung Veterans General Hospital · ORCID：0000-0001-7860-4320

发表论文 198 篇 · 总被引 3280 次 · h-index 32

代表论文

• Chemotherapy With Or Without Pembrolizumab Followed By Maintenance With Olaparib Or Placebo For First-Line Treatment Of Advanced BRCA Non-Mutated Epithelial Ovarian Cancer: Results From The Randomized Phase 3 ENGOT-OV43/GOG-3036/KEYLYNK-001 Study (2025 · International Journal of Gynecological Cancer · 被引 19)
• Global burden of disease for musculoskeletal disorders in all age groups, from 2024 to 2050, and a bibliometric-based survey of the status of research in geriatrics, geriatric orthopedics, and geriatric orthopedic diseases (2025 · Journal of Orthopaedic Surgery and Research · 被引 8)
• A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma (2025 · BMC Medicine · 被引 7)
• Gestational diabetes: a contributor to long-term thyroid dysfunction and disease (2025 · Frontiers in Endocrinology · 被引 5)
• Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer (2025 · BMC Medicine · 被引 5)
• Hemoperfusion membranes based on molecularly imprinted membranes of dual-crosslinked polyethyleneimines for efficient plasma bilirubin removal viafrequency-tuned alternating current electric fields (2025 · Journal of Membrane Science · 被引 4)